Advice
in the absence of a submission from the holder of the marketing authorisation:
ivabradine (Procoralan®) is not recommended for use within NHS Scotland.
Indication under review: Symptomatic treatment of chronic stable angina pectoris in coronary artery disease adults with normal sinus rhythm, in combination with beta-blockers, in patients inadequately controlled with an optimal beta-blocker dose and whose heart rate is > 60 bpm.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.
Download detailed advice69KB (PDF)
Medicine details
- Medicine name:
- ivabradine (Procoralan)
- SMC ID:
- 689/11
- Indication:
- Symptomatic treatment of chronic stable angina pectoris in coronary artery disease adults with normal sinus rhythm, in combination with beta-blockers, in patients inadequately controlled with an optimal beta-blocker dose and whose heart rate is > 60 bpm.
- Pharmaceutical company
- Servier Laboratories Ltd
- BNF chapter
- Cardiovascular system
- Submission type
- Non submission
- Status
- Not recommended
- Date advice published
- 07 February 2011